TScan Therapeutics, Inc. (TCRX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $105.67M | -18.8% |
| 2024 | $130.15M | +7.3% |
| 2023 | $121.28M | +21.7% |
| 2022 | $99.66M | +264.7% |
| 2021 | $27.33M | -16.0% |
| 2020 | $32.52M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $105.67M | -18.8% |
| 2024 | $130.15M | +7.3% |
| 2023 | $121.28M | +21.7% |
| 2022 | $99.66M | +264.7% |
| 2021 | $27.33M | -16.0% |
| 2020 | $32.52M | — |